Community use of intravenous tissue plasminogen activator for acute stroke - Results of the brain matters stroke management survey - Editorial Comment

被引：0
|
作者：
Howse, DC [1 ]
机构：
[1] Queens Univ, Dept Med, Div Neurol, Kingston, ON K7L 3N6, Canada
来源：
STROKE | 2001年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：864 / 865
页数：2
相关论文
共 50 条
  • [31] A Stroke Registry Data on the Use of Intravenous Recombinant Tissue Plasminogen Activator in Stroke of Unknown Time of Onset
    Balogun, Ibrahim O.
    Brown, Aaron
    Bertoni, Miguel
    Webb, Thomas
    Hargroves, David
    Pullicino, Patrick
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2016, 25 (08): : 1843 - 1850
  • [32] Use of recombinant tissue plasminogen activator in cancer patients with acute stroke
    Jerome J. Graber
    Lakshmi Nayak
    Lisa M. DeAngelis
    [J]. Journal of Neuro-Oncology, 2012, 107 : 571 - 573
  • [33] Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA)
    Eissa, A.
    Krass, I.
    Bajorek, B. V.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2012, 37 (06) : 620 - 629
  • [34] Use of recombinant tissue plasminogen activator in cancer patients with acute stroke
    Graber, Jerome J.
    Nayak, Lakshmi
    DeAngelis, Lisa M.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (03) : 571 - 573
  • [35] Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
    Chapman, Sherita N.
    Mehndiratta, Prachi
    Johansen, Michelle C.
    McMurry, Timothy L.
    Johnston, Karen C.
    Southerland, Andrew M.
    [J]. VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 75 - 87
  • [36] Estimated cost savings of increased use of intravenous tissue plasminogen activator for acute ischemic stroke in Canada
    Yip, Todd R.
    Demaerschalk, Bart M.
    [J]. STROKE, 2007, 38 (06) : 1952 - 1955
  • [37] Racial and Ethnic Disparities in the Use of Intravenous Recombinant Tissue Plasminogen Activator and Outcomes for Acute Ischemic Stroke
    Nasr, Deena M.
    Brinjikji, Waleed
    Cloft, Harry J.
    Rabinstein, Alejandro A.
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (02): : 154 - 160
  • [38] Intravenous Recombinant Tissue-type Plasminogen Activator Use in Young Adults With Acute Ischemic Stroke
    Dodds, Jodi A.
    Xian, Ying
    Sheng, Shubin
    Fonarow, Gregg
    Matsouaka, Ronald A.
    Bhatt, Deepak L.
    Peterson, Eric
    Schwamm, Lee H.
    Smith, Eric E.
    [J]. STROKE, 2017, 48
  • [39] Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke:: Relation to stroke etiology
    Zunker, P
    Schick, A
    Padró, T
    Kienast, J
    Phillips, A
    Ringelstein, EB
    [J]. NEUROLOGICAL RESEARCH, 1999, 21 (08) : 727 - 732
  • [40] Obstacles to the use of intravenous tissue plasminogen activator for acute ischemic stroke. Is time the only barrier ?
    Laloux, Patrice
    Thus, Vincent
    Peeters, Andre
    Desfontaines, Philippe
    [J]. ACTA NEUROLOGICA BELGICA, 2007, 107 (04) : 103 - 107
12345